SLC1A3 is a novel prognostic biomarker associated with immunity and EMT in hepatocellular carcinoma
Abstract Purpose Solute carrier family 1 member 3(SLC1A3), a member of the glutamate transporter family, is implicated in the progression of gastric carcinoma and the renewal of thyroid carcinoma stem cells. The purpose of this work is to use experimental validation and bioinformatics analysis to lo...
Saved in:
| Main Authors: | Renhou Zhi, Fan Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01561-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of ribosomal protein S21 as a potential prognostic and immunotherapy biomarker for hepatocellular carcinoma
by: Junhan Pan, et al.
Published: (2025-01-01) -
Establishment of prognostic risk model related to disulfidptosis and immune infiltration in hepatocellular carcinoma
by: Zhe Xu, et al.
Published: (2024-12-01) -
Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma
by: Chang-Qing Yin, et al.
Published: (2024-12-01) -
Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma
by: Guohong Yan, et al.
Published: (2025-01-01) -
Exploration of ANKRD27 as an immune-related prognostic factor in pan-cancer and hepatocellular carcinoma
by: Ningzhe Shen, et al.
Published: (2025-01-01)